DK159853C - Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK159853C
DK159853C DK096983A DK96983A DK159853C DK 159853 C DK159853 C DK 159853C DK 096983 A DK096983 A DK 096983A DK 96983 A DK96983 A DK 96983A DK 159853 C DK159853 C DK 159853C
Authority
DK
Denmark
Prior art keywords
acceptable
erythromycin
isopropylide
acylates
epi
Prior art date
Application number
DK096983A
Other languages
English (en)
Other versions
DK159853B (da
DK96983A (da
DK96983D0 (da
Inventor
James Robert Hauske
Frank Christian Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK96983D0 publication Critical patent/DK96983D0/da
Publication of DK96983A publication Critical patent/DK96983A/da
Publication of DK159853B publication Critical patent/DK159853B/da
Application granted granted Critical
Publication of DK159853C publication Critical patent/DK159853C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK096983A 1982-03-01 1983-02-28 Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf DK159853C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/353,548 US4382086A (en) 1982-03-01 1982-03-01 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
US35354882 1982-03-01

Publications (4)

Publication Number Publication Date
DK96983D0 DK96983D0 (da) 1983-02-28
DK96983A DK96983A (da) 1983-09-02
DK159853B DK159853B (da) 1990-12-17
DK159853C true DK159853C (da) 1991-05-13

Family

ID=23389607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK096983A DK159853C (da) 1982-03-01 1983-02-28 Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (8)

Country Link
US (1) US4382086A (da)
EP (1) EP0087916B1 (da)
JP (1) JPS58159500A (da)
DE (1) DE3361453D1 (da)
DK (1) DK159853C (da)
GR (1) GR77921B (da)
IE (1) IE54431B1 (da)
YU (1) YU42841B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421429D0 (en) * 1984-08-23 1984-09-26 Beecham Group Plc Chemical compounds
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
ES552858A1 (es) 1985-03-12 1987-11-01 Beecham Group Plc Un procedimiento para la preparacion de derivados de eritromicina.
US4681872A (en) * 1985-11-12 1987-07-21 Abbott Laboratories Erythromycin A 11,12-carbonate and method of use
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
CA2094060A1 (en) * 1990-10-15 1992-04-16 Toshifumi Asaka 2'-position modified compound of erythromycin or its derivative
EP1482957A4 (en) * 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
US20040005641A1 (en) * 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070174A2 (en) * 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1532131B1 (en) * 2002-08-29 2008-12-17 Pfizer Inc. Motilide compounds
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
JP2009502838A (ja) * 2005-07-26 2009-01-29 メルクレ，ゲーエムベーハー ピロリジンおよびインドリジン化合物のマクロライド接合体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) * 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US3417077A (en) * 1966-05-16 1968-12-17 Lilly Co Eli Erythromycin derivative and process for the preparation thereof
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives

Also Published As

Publication number Publication date
EP0087916A1 (en) 1983-09-07
DK159853B (da) 1990-12-17
YU42841B (en) 1988-12-31
IE54431B1 (en) 1989-10-11
DE3361453D1 (en) 1986-01-23
DK96983A (da) 1983-09-02
DK96983D0 (da) 1983-02-28
GR77921B (da) 1984-09-25
YU45983A (en) 1986-02-28
JPS58159500A (ja) 1983-09-21
JPH0142275B2 (da) 1989-09-11
IE830410L (en) 1983-09-01
EP0087916B1 (en) 1985-12-11
US4382086A (en) 1983-05-03

Similar Documents

Publication Publication Date Title
DK162601C (da) Analogifremgangsmaade til fremstilling af 8-oe4-oe4-(2,1-benzisothiazol-3-yl)-1-piperazinylaabutylaa-8-azaspirooe4.5aadecan-7,9-dion
DK158873C (da) Fremgangsmaade til stabilisering af et lyofiliseret farmaceutisk interferonpraeparat
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
DK158269C (da) Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater
DK149846C (da) Analogifremgangsmaade til fremstilling af n,n'-bis-tetrahydro-isoquinolyldisulfonylimider
DK148537C (da) Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf
DK163181C (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK154557C (da) Analogifremgangsmaade til fremstilling af 3,4-dihydro-8-((2-hydroxy-3-alkylamino)-propoxy)-2h-1-benzopyranderivater eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK159853C (da) Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK113483D0 (da) Fremgangsmade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK24083A (da) Fremgangsmaade til fremstilling af 0,0'-dithiodibenzoesyrer
DK160875C (da) Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
ES510913A0 (es) "un procedimiento para la preparacion de derivados de piridina".
DK148903C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf
DK151021C (da) Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf
DK150481C (da) Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
DK398283D0 (da) Fremgangsmade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK157025C (da) Analogifremgangsmaade til fremstilling af 4h-furo(3,2-b)indoler eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PUP Patent expired